Binge-eating disorder persists longer than previously thought, study shows

FHS
May 28, 2024
5:15 pm

Binge-eating disorder is the most prevalent eating disorder in the United States, but previous studies have presented conflicting views of the disorder’s duration and the likelihood of relapse.

Abivax Announces First Patient Enrolled in ENHANCE-CD, the Phase 2b Trial of Obefazimod in Crohn’s Disease – Biotech Investments

EQS-News: ABIVAX / Key word(s): Study Abivax Announces First Patient Enrolled in ENHANCE-CD, the Phase 2b Trial of Obefazimod in Crohn’s Disease 03.10.2024 / 22:01

October 4, 2024

Federal agency opposes J&J’s new 340B discount model, promises to take ‘actions as warranted’

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

August 27, 2024

Psychedelic Bulletin #146: Numinus Drops Lab, Consolidates Clinics; Study Suggests DMT Safe and Effective Alongside SSRI; Preprint Calls Intracellular Theory of Psychedelic-induced Neuroplasticity Into Question; A Cole Memo for Psychedelics? – Psychedelic Alpha

💸 GlobalData forecasts $7.2bn psychedelic drug market in 2029. The company shared the projection earlier this week, but it looks a little off. For starters, the

September 29, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.